Introduction
Central nervous system (CNS) complications occur in 40-50% of people living with HIV/AIDS, even those receiving combination antiretroviral therapy (cART) [1, 2] . Collectively known as HIV-1-associated neurocognitive disorders (HAND), these impairments manifest largely as asymptomatic or mild disease. More severe CNS disease, including HIV-associated dementia, has been diminished by cART, but remains problematic in more resource-limited settings [3] . HIV-1 invades the CNS soon after systemic infection, predominantly infecting perivascular macrophages, microglia, and less frequently astrocytes, within the brain parenchyma [4, 5] . It has been occasionally reported that human neural progenitor cells (hNPCs), which generate all CNS neurons and macroglia, can harbor infection [6] [7] [8] , although this remains controversial. The cumulative response of infected CNS cells promotes inflammatory and toxic conditions, the combination of which leads to neuronal injury and synaptic dysfunction [9, 10] . Sublethal damage to the integrity of dendrites and synapses is considered the basis of neurological impairments associated with HAND [11] .
Substance abuse is a major comorbidity associated with HIV-1 disease progression [12, 13] , as highlighted by the recent heroin crisis and concurrent outbreaks of HIV infection among new injection drug abusers in the United States [14, 15] . Studies have established strong links between opiate abuse and HIV-1 neuropathogenesis [16] [17] [18] [19] [20] . Morphine, the major metabolite of heroin, reportedly potentiates CNS viral replication [21, 22] , and enhances the neurodegenerative effect of HIV-1 via reverberating inflammatory/neurotoxic signaling between infected and/or activated CNS cells [23, 24] . Opiates associated with abuse liability modulate HIV-1 neuropathogenesis through actions primarily on m-opioid receptors (MORs). Although MORs are expressed by both neurons and glia, neuropathological effects of opiates appear to largely be mediated by glia [25] . Despite this, current understanding of how opiates augment HIV-1 neuropathology remains incomplete.
Because NPCs express MORs and are reportedly targeted by both HIV-1 [26] [27] [28] [29] [30] and opiates [26, 28, [31] [32] [33] , we examined their contribution to HIV-1 and opiatemediated neuropathogenesis. We re-evaluated the possibility that hNPCs may be infected using CCR5-tropic (R5) HIV-1 BaL and a primary hNPC culture system, and systematically confirmed that HIV-1 BaL infects hNPCs. A serial dilution and infection approach demonstrated that hNPCs propagate de-novo viral infection; morphine interacted to sustain productive infection. In addition, we explored the effects of HIV-1 on hNPC function. HIV sup exposure reduced proliferation and induced premature differentiation of hNPCs into both astrocytes and neurons; effects were significantly enhanced by morphine co-exposure. Ultraviolet (UV) light inactivation showed that infection was not required for HIV/morphine-dependent alterations in proliferation, which were likely due to factors in the infectious supernatant.
We speculate that HIVand opiate-mediated disruptions in the genesis of new CNS cells may create a numerical imbalance in overall neuronal and glial populations. This may be critical in the developing brain of children and adolescents, and for maintaining neuroplasticity in the adult brain. Importantly, infection of hNPCs and perhaps their progeny may create an additional viral reservoir in the CNS compartment. The recent escalation in opioid dependence and misuse, which includes adolescents and women of child-bearing age, underscores the potential clinical importance of our findings.
Materials and methods

Ethics statement
All human tissues were purchased from biological supply vendors, were anonymized, and not classified as human subjects research.
Primary human neural progenitor cell culture Human NPCs were derived from anonymized 8-10-week-old brain samples (Advanced Bioscience Resources, Alameda, California, USA), a developmental stage, where mature, ramified microglia are generally absent [34] . 'Supplemental Data' describes isolation, characterization, and culture.
HIV-1 propagation
PBMCs isolated from peripheral blood Leuko Paks (ZenBio, Research Triangle Park, North Carolina, USA) via Ficoll gradient centrifugation were activated with phytohemagglutinin (PHA) (1 mg/ml), then infected with HIV-1 BaL (Advanced Biotechnology, Eldersburg, Maryland, USA; 1 ng/ml p24) for 72 h. Infection was assayed using p24 Antigen ELISA kit (Advanced Bioscience, Rockville, Maryland, USA).
Human neural progenitor cell infection
Human NPCs were exposed to purified HIV-1 BaL for 24 h, washed thoroughly to remove residual virus, and incubated in NPC media.
Treatments for proliferation/differentiation assays Human NPCs were treated with supernatant from HIV-infected PBMCs (HIV sup ) at 0.5-500 pg/ml p24. Controls included media only, and equal volumes of supernatant from uninfected, PHA-activated PBMCs at the same initial cell density. Morphine (500 nmol/l) was added coincident with supernatant. For UV inactivation, a sample of HIV sup was UV-cross-linked (1200 J/m 2 , 5 min).
Immunostaining/bromodeoxyuridine Fixation, processing, and antibodies are detailed in 'Supplemental Data.' Samples were imaged using a Zeiss LSM 700 laser scanning confocal microscope (20/63Â magnification). Images were collected using ZEN 2009 Light Edition software (Carl Zeiss, New York, New York, USA).
RT-PCR
Target genes were amplified from hNPC cDNA via PCR using Bioline MangoMix or Roche FastStart DNA Master SYBR Green and gene-specific primer sets. Supplemental Data contains primer sequences.
Cell growth and doubling-time Doubling-time was calculated using the equation D(t) ¼ T ln2/ln(X e /X b ) (ATCC Animal Cell Culture Guide). Supplemental Data describe cell density determination.
Statistics
Analyses were performed using GraphPad Prism 5 software (GraphPad Software, Inc, La Jolla, California, USA). Unless indicated, data were analyzed by one-way analysis of variance (ANOVA) followed by Bonferroni post-hoc testing. P < 0.05 was considered significant.
Results
Characterization of primary human neural progenitor cell cultures Human cells may more accurately reproduce disease features involving species-dependent interactions. Human NPCs were derived from 8-10-week gestational brain tissues. To minimize variability, samples were carefully matched for age, sex, and passage number, and cell composition was characterized at each passage. Results showed that more than 90% expressed NPC markers nestin and/or sex-determining region Y-box 2 (SOX2), with smaller percentages expressing the astrocytic marker glial fibrillary acidic protein (GFAP) (<20%) or the neuronal marker microtubule-associated protein 2 (MAP2) (<5-10%). Within populations expressing GFAP and MAP2, 80-90% also expressed SOX2, indicating maintenance of an immature phenotype ( Fig. 1 a and b) . PCR findings demonstrated that cells HIV-1 and morphine interaction in human NPCs Balinang et al.
755 expressed the NPC genes PAX3 and NOTCH1, the astrocyte gene aldehyde dehydrogenase 1 family member L1 (ALDH1L1), and the neuronal gene DLG4 that encodes human postsynaptic density protein 95 (PSD-95) (Fig. 1c) . We did not detect the expression of oligodendrocyte gene, myelin basic protein (MBP). This is likely due to the immaturity of the tissue, as MBP gene expression is not detected in CNS tissues except spinal cord prior to 12-15-week gestation [35] [36] [37] . The sex of each culture was determined by the presence of Y and X-chromosome-related genes (Fig. 1c) . CNS tissue at this early embryonic stage is assumed to be largely sexually undifferentiated and bipotent [38] . Nevertheless, to avoid any sex differences, which have been noted in glial populations [39, 40] , we only used male cultures.
Sustained and productive infection of human neural progenitor cells by R5 HIV-1 BaL
To determine the contribution of hNPCs to combined HIV-1 and opiate neuropathogenesis, we first reassessed prior reports that hNPCs could be infected by HIV-1 [6, 8, 41] . De novo infection was confirmed by monitoring production of HIV-1 transcripts and proteins using multiple methods. PCR analysis indicated expression of HIV-1 tat in hNPCs 72 h after infection at all HIV-1 BaL concentrations (Fig. 2a) . Robust HIV-1 Nef immunoreactivity was also observed in 5-8% of HIV-1 BaL -treated hNPCs (Fig. 2b) . The presence of microglia, macrophages, and T cells was examined to rule out potential contributions to infectivity results. The microglia/ macrophage-specific Iba-1 protein and transcript were not detected ( Fig. 2b and c ), nor were other human microglia/macrophage genes including CX3CR1 and CD11b, and T cell genes CD4 and CD8A ( Fig. 2c and d) . Furthermore, earlier studies [6, 7] of p24 production in the culture supernatant of infected hNPCs were confirmed by ELISA (Fig. 2e , g, and h), CCR5 inhibitor maraviroc, but not CXCR4 inhibitor AMD3100, effectively suppressed p24 production in hNPC cultures infected with 100 and 10 ng/ml HIV BaL (Fig. 2e ).
To test whether the infection was productive, we adapted a serial dilution and passaging approach. Initial infections were performed by treating hNPCs with purified HIV-1 BaL ; infection was confirmed 3 days after wash by ELISA. Supernatant was removed and diluted (1 : 100), then placed on naive hNPCs for 3 days. Three serial dilutions were performed and p24 was measured at the end of each infection period (Fig. 2f ). In the absence of new infection, the p24 level is expected to decline at each passage. Instead, p24 levels were sustained over time, suggesting that the infection was productive and transferable (Fig. 2g) . Morphine did not augment the infectivity of hNPCs, even when the infection period was extended to 5 days (not shown). The findings from these multiple experimental approaches show that R5 HIV-1 can infect primary hNPCs, and also that hNPCs are capable of propagating de novo infection in vitro.
Morphine sustains productive R5 infection of human neural progenitor cells
The effect of morphine on infection was further analyzed at later stages. hNPCs were initially infected with purified HIV-1 BaL (1.0-100 ng/ml p24), then monitored for p24 production in cultures AE morphine for up to 15 days. A gradual increase in p24 production was measured irrespective of the initial HIV titer, was sustained for up to 12 days, and eventually plateaued after 15 days. Morphine enhanced p24 levels at 12 and 15 days after infection when hNPCs were initially infected at100 ng/mlp24 (Fig. 2h) .Morphine also increased tat mRNA levels at 9 days after infection, a period preceding the morphine interaction on p24 (Fig. 2i) . The difference in p24 production and tat expression was not due to death of hNPCs exposed to HIV-1 BaL AE morphine since no differences in DNA content between groups were observed (Fig. 2j) .
HIV-1 and morphine affect DNA synthesis and doubling time We next tested whether HIV-1 and morphine coexposure affected hNPC proliferation and doubling time.
To model inflammatory conditions associated with HIV infection, we treated hNPCs with HIV sup at multiple p24 levels. Soluble factors contained in HIV sup and uninfected supernatant (UNF sup ) were compared using human cytokine arrays (Supplemental Fig. 1 , http://links.lww. com/QAD/B39). Bromodeoxyuridine (BrdU) was used to label cells entering the S-phase of DNA synthesis. BrdU immunoreactivity was significantly decreased versus media control at 24 h in hNPCs treated with higher HIV sup concentrations (50 and 500 pg/ml p24), and in all tested HIV sup concentrations at 48 h. Significant differences between the HIV sup and the UNF sup controls at 24 h (500 pg/ml p24) and 48 h (50-500 pg/ml p24) indicated a specific response to the infection per se (Fig. 3a) . Morphine enhanced this effect, as evidenced by further reduction of BrdU labeling in hNPCs treated with combined HIV sup and morphine ( Fig. 3b and d) .
Changes in DNA synthesis were reflected in hNPC replication. hNPCs were treated for 5 days with HIV sup at concentrations in which interactive effects on BrdU incorporation were observed. Cell density was measured every 24 h to calculate the population doubling time. Co-exposure to morphine at higher HIV sup concentrations significantly prolonged doubling time (Table 1 Supplementary Data, http://links.lww.com/QAD/B39). Effects on proliferation and cell division were not attributable to changes in cell death (Fig. 3c) .
HIV-1 and morphine affect human neural progenitor cell differentiation Human NPCs were treated with HIV sup (50 and 500 pg/ml p24) AE morphine for 12 days, and immunolabeled with antibodies to nestin, SOX2, GFAP, and MAP2. Compared to controls, cultures treated with both HIV sup concentrations had significantly higher samples. ( Ã ) P < 0.05 vs. HIV 100 alone. (i) Quantification of tat mRNA expression in hNPCs exposed to HIV-1 BaL at concentrations of 1.0 ng/ml (H1.0), 10 ng/ml (H10), or 100 ng/ml (H100) p24 alone or with morphine (M) for 9 days. (j) Spectrophotometric measurement of total DNA content from hNPC cultures exposed to morphine, purified HIV-1 BaL at 10 ng/ml p24 (H10) or 100 ng/ ml p24 (H100) alone or with morphine (M) for 15 days. Unless noted, error bars show mean AE SEM from three hNPC cultures derived from independent tissue samples. ( Ã ) P < 0.05. hNPC, human neural progenitor cell; SEM, standard error of mean. percentages of both GFAP þ and MAP2 þ cells. HIV-1 and morphine interactions were observed on neuronal and astroglial differentiation, evidenced by increased percentages of MAP2 þ cells in response to morphine and HIV sup at 50 and 500 pg/ml p24, and GFAP þ cells in response to morphine and HIV sup at 500 pg/ml p24. The ratio of neurons to astroglia was unchanged by any treatment (data not shown). It is notable that despite the increased expression of MAP2 and GFAP upon HIV sup AE morphine treatment, the percentage of nestin and SOX2-expressing cells was unchanged (Fig. 4a and b) .
HIV-1 infection is not required for effects on proliferation As hNPCs were productively infected by HIV-1, we tested whether infection underlies the functional responses of hNPCs by comparing the effects of UV-inactivated HIV sup and concentrated HIV-1 virions. UV irradiation inactivates virions in infective supernatant without eliminating inflammatory or other deleterious factors. Inactivation was confirmed by lack of p24 production by PBMCs after exposure to UVirradiated HIV (Fig. 5a) . Analysis showed that 48 h exposure to concentrated HIV-1 BaL did not change the percentage of BrdU þ hNPCs relative to control. However, a significant decrease of BrdU incorporation was observed in hNPCs treated with UV-inactivated supernatant (Fig. 5b) . Thus, changes in hNPC proliferation are not due to infection per se, but rather mediated by the combined effect of inactive virions, HIV proteins, and inflammatory conditions created by infected cells. 
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Discussion
We demonstrated that hNPCs are targets for HIV-1 infection at two levels. Conditions created by HIV-1 infection significantly restrict hNPC proliferation and alter the dynamics of their differentiation. Also, hNPCs can be infected and can propagate infection, at least under certain conditions in vitro. Many outcomes were exacerbated by opiate co-exposure. Injection drug abuse is a major vector for HIV transmission, and opiate abuse is re-emerging as a major public health crisis, underscoring the likely clinical importance of HIV and opiate interactions.
NPCs are present throughout the developing brain, and persist in the dentate gyrus and subventricular zone of the adult brain [42] . They are highly mitotic and migratory during development, and while adult NPCs are more quiescent, they can be activated to proliferate, particularly in response to insult/injury [43] . Aberrant NPC behavior can perturb the balance of CNS populations, and the consequences of hNPC dysfunction have been implicated in various psychiatric [44, 45] and neurodegenerative diseases [46] , and also in injuries caused by inflammation [47, 48] , stroke/ischemia [43] , or epilepsy [49] . However, responses of fetal hNPCs to HIV may of course differ from those in the adult CNS.
The concept that hNPCs may be infected by HIV-1 has remained controversial despite studies showing limited p24 production by fetal-derived hNPCs exposed to HIV-1 IIIB and HIV-1 NL4-3 [7] , and the presence of pro-viral DNA in a human neural stem cell line treated with HIV-1 IIIB [6] . The presence of viral DNA was also noted in nestin þ hNPCs microdissected from the hippocampus of pediatric AIDS patients [8] . We hoped to clarify this controversy by systematically examining the capacity of hNPCs from multiple independent samples to be infected and to propagate infection. De novo infection resulted in detection of tat, Nef, and p24. PCR confirmed that microglia, monocytes/macrophages, and T cells were absent from cultures and could not contribute to infection. Confident that a small percentage of hNPCs were infected, we tested whether infection could be transferred to naive cells. The p24 titer was sustained even after three dilution/infection cycles, providing compelling evidence that hNPCs can actively propagate HIV-1 infection. No evidence of CD4 expression was observed, suggesting a CD4-independent mechanism for infection. Given that CCR5 and CXCR4 are expressed in immortalized hNPCs [30] , we tested whether these HIV co-receptors were involved in hNPC infection. Using CCR5 and CXCR4 inhibitors, we determined that infection was partly mediated by CCR5. Other receptors/modes of entry are likely as p24 production was not completely blocked by maraviroc, and there was considerable variability in the response to maraviroc.
Human NPCs were only infected at relatively high viral titers, suggesting that NPCs in close proximity to HIVinfected microglia/macrophages may be most vulnerable. In adults, this likely occurs in NPC-rich brain regions such as the hippocampus, where a high density of infected microglia and macrophages has been demonstrated [50] . Viral tropism may also influence the capacity for hNPC infection. Studies here used R5 HIV-1 BaL , but hNPCs might also be susceptible to infection by other strains, perhaps requiring lower viral titers to achieve infection. Two studies reported evidence of p24 production in progenitor cultures exposed to X4-tropic HIV-1 IIIB [6, 7] . Whereas R5 viruses represent the predominant virus population early after infection, X4 viruses are generally associated with heightened virulence, rapid CD4 þ T cell decline, CNS injury, and accelerated AIDS progression [51] [52] [53] [54] [55] . The likelihood of hNPC infection is increased if they are vulnerable to multiple strains. Exposure to HIV sup at p24 levels measured in infected brains [56, 57] affected critical hNPC functions. HIV sup dramatically decreased BrdU incorporation and prolonged hNPC doubling-time. Similar effects on proliferation were previously observed with HIV-1 proteins [26, 27, 29, 58] , and on immortalized hNPCs [26] . Hippocampal tissue from autopsied HIV-1 dementia patients showed reduced Ki-67 þ cells [27] , which would be consistent with reduced NPC proliferation. In contrast, supernatant from lipopolysaccharide (LPS)-stimulated, HIV-infected macrophages increased hNPC proliferation [30] , although the proliferative effects of acute LPS exposure posed a confound [59] . Morphine co-exposure accentuated the effect of HIV sup on hNPC proliferation, paralleling interactions previously reported between morphine and HIV-1 Tat on fetal hNPCs [28] , and morphine and HIV-1 Tat or HIV sup on immortalized hNPCs [26] . Effects were unrelated to hNPC survival, which was unchanged by any treatment. Morphine by itself did not alter hNPC proliferation, although this was reported in rodent NPCs [31, 33] and hNPCs [28] , perhaps reflecting species or timing differences.
We also found that HIV sup exposure resulted in premature differentiation of hNPCs into both neurons and astrocytes. Morphine co-exposure significantly enhanced this effect. HIV sup AE morphine effects on proliferation and differentiation suggest that extended exposure will alter the balance/size of MAP2 þ and GFAP þ cell populations. Meaningful in vivo assessments of this will require stereological analysis of potentially affected brain regions.
Are these in vitro results relevant to human disease? NPCs are present in both developing and adult systems, albeit in different regions. Adult and immature NPCs also have unique characteristics that may influence their response to HIV infection and to opiate exposure. An accurate balance between NPC proliferation and differentiation is necessary for establishing and maintaining cell populations, and perturbations to these regulated processes can influence overall CNS architecture and function [60] [61] [62] . Cortical atrophy is a common feature of pediatric neuroAIDS, especially in cART-naive children [63, 64] . The reduced NPC production and early differentiation described here may contribute to cortical atrophy and other neurological manifestations in children and adolescents with HIV-1 [41, 65, 66] . Although cART has greatly reduced HAND incidence in children, currently 2.6 million children worldwide are infected with HIV-1, and children represent 1-2% of cases in the United States (http://www.who.int/hiv/en/).
Unlike NPCs in the developing brain, adult NPCs are restricted to the subventricular zone and subgranular zone of the hippocampal dentate gyrus [42, 67] . There is a strong correlation between hippocampal atrophy/dysfunction and reduced spatial recognition and learning/ memory ability, both in HIV experimental models [68] [69] [70] [71] [72] and in patients [73] [74] [75] . The hippocampus of HIV-1-infected adults exhibits high viral load [50] and often shows significant atrophy [75, 76] , suggesting that NPCs may have limited expansion. Interestingly, the proliferation of hippocampal NPCs from adult patients with HIV-1 dementia was significantly reduced when compared to infected patients without dementia, also suggesting that hippocampal impairments might involve failure to generate normal numbers of adult NPCs [27] .
There could be multiple clinical consequences of productive hNPC infection. First, infected hNPCs might augment overall CNS disease by increasing the levels of virus, viral proteins, and inflammation in the brain. The ability of HIV-1 infection to disrupt hNPC proliferation without affecting viability might promote HIV neurovirulence, similar to other cells with active viral replication. The virus may be able to maintain persistent infection by switching host DNA synthesis to viral DNA synthesis in infected cells [77] , as has been shown for hNPCs infected with human cytomegalovirus [78] . Secondly, infected hNPCs may pass the infection to long-lived progeny, generating new viral reservoirs and new barriers for eradication. In support of this concept, inflammatory mediators such as tumor necrosis factor (TNF)-a [7] and interleukin (IL)-1b [79] were found to reactivate viral production in cultured NPC-derived astrocytes. The ability of NPCs to pass infection to progeny might also explain reports of infected, immature neurons [80, 81] .
Morphine exacerbated the effect of HIV-1 on proliferation and differentiation, and sustained de novo viral production in vitro. If these results can be extrapolated to the human brain, it suggests that the extent of dysfunction and infection in both adult and young NPCs will increase with opiate co-exposure. These findings are especially concerning given the current opiate drug crisis. Heroin use and overdose-related hospitalizations have markedly increased over the past 10 years [82, 83] ; the number of heroin users nearly tripled between 2005 and 2012 [84] . A major, coincident, consequence of increased opiate abuse has been the rising outbreak of HIV-1 infection outside urban communities, where new infections occur frequently in young adults, almost half of whom are women [14, 15] . Although perinatal transmission has been significantly decreased by cART, the Centers for Disease Control and Prevention (CDC) reported 174 new cases of HIV in children in the United States in 2014, and 1999 total children living with perinatal HIV. Furthermore, the CDC estimated that 9131 adults and adolescents were living with HIV acquired perinatally (http://www.cdc. gov/hiv/group/gender/pregnantwomen/). Importantly, maternal drug use is strongly associated with increased risk of perinatal transmission [85, 86] . A high percentage of children and young adults with HIV/AIDS also receive opiates for pain intervention, as pain prevalence among this group is reportedly as high as 60% [87] .
Our study shows that hNPCs are capable of sustaining and propagating HIV-1 infection. The infective milieu also causes functional deficits in uninfected hNPCs. Dysregulation of these proliferative, multipotent cells by HIVmediated inflammatory/toxic insults may intensify neuropathology, and may especially affect the developing brains of HIV-infected children and adolescents. Infected hNPCs may also serve as an additional CNS viral reservoir. The significant interactions between morphine and HIV suggest that HIV-1 patients with a history of opiate abuse or exposure may be particularly vulnerable to HIV-related cognitive and motor deficits.
